Cross talk between primary human renal tubular cells and endothelial cells in cocultures

American Journal of Physiology - Renal Physiology

Volumn 302, Issue 8, 2012, Pages

  Tasnim, Farah ^a   Zink, Daniele ^a  

^a INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

Author keywords

Communication of renal cells; Defined microenvironment; Primary human renal proximal tubular cells; Transforming growth factor ; 2 macroglobulin

Indexed keywords

ALPHA 2 MACROGLOBULIN; RECOMBINANT ALPHA 2 MACROGLOBULIN; RECOMBINANT PROTEIN; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CELL COMMUNICATION; CELL PROLIFERATION; CELL STIMULATION; COCULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN PRIMARY RENAL PROXIMAL TUBULAR CELL; KIDNEY DISEASE; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; MARKER GENE; MICROENVIRONMENT; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN SECRETION;

EID: 84859734598     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00621.2011     Document Type: Article

References (44)

1. Bach PH, Obatomi DK, Brant S. In vitro methods for nephrotoxicity screening and risk assessment. In: In Vitro Methods in Pharmaceutical Research, edited by Castell JV and Gomez-Lechon MJ: San Diego, CA: Academic, 1997, p. 55-101.
2. Brenner BM. Brenner and Rector's The Kidney. Philadelphia, PA: Saunders Elsevier, 2008.
3. Elberg G, Guruswamy S, Logan CJ, Chen L, Turman MA. Plasticity of epithelial cells derived from human normal and ADPKD kidneys in primary cultures. Cell Tissue Res 331: 495-508, 2008.
4. Fan JM, Ng YY, Hill PA, Nikolic-Paterson DJ, Mu W, Atkins RC, Lan HY. Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int 56: 1455-1467, 1999.
5. Ferrara N. Vascular endothelial growth factor. Arterioscler Thromb Vasc Biol 29: 789-791, 2009.
6. Gould SE, Day M, Jones SS, Dorai H. BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells. Kidney Int 61: 51-60, 2002.
7. Huang SS, Huang JS. TGF-beta control of cell proliferation. J Cell Biochem 96: 447-462, 2005.
8. Kanellis J, Fraser S, Katerelos M, Power DA. Vascular endothelial growth factor is a survival factor for renal tubular epithelial cells. Am J Physiol Renal Physiol 278: F905-F915, 2000.
9. Kang DH, Anderson S, Kim YG, Mazzalli M, Suga S, Jefferson JA, Gordon KL, Oyama TT, Hughes J, Hugo C, Kerjaschki D, Schreiner GF, Johnson RJ. Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis 37: 601-611, 2001.
10. Lian YG, Zhou QG, Zhang YJ, Zheng FL. VEGF ameliorates tubulointerstitial fibrosis in unilateral ureteral obstruction mice via inhibition of epithelial-mesenchymal transition. Acta Pharmacol Sin 32: 1513-1521, 2011.
11. Liu Y. Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 7: 684-696, 2011.
12. Maeshima Y, Makino H. Angiogenesis and chronic kidney disease. Fibrogenesis Tissue Repair 3: 13, 2010.
13. Matsumoto K, Nakamura T. Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. Kidney Int 59: 2023-2038, 2001.
14. Miya M, Maeshima A, Mishima K, Sakurai N, Ikeuchi H, Kuroiwa T, Hiromura K, Yokoo H, Nojima Y. Enhancement of in vitro human tubulogenesis by endothelial cell-derived factors: implications for in vivo tubular regeneration after injury. Am J Physiol Renal Physiol 301: F387-F395, 2011.
15. Montesano R, Matsumoto K, Nakamura T, Orci L. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67: 901-908, 1991.
16. Nakamura T, Mizuno S. The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine. Proc Jpn Acad Ser B Phys Biol Sci 86: 588-610, 2011.
17. Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 17: 17-25, 2006.
18. Ni M, Teo JC, Ibrahim MS, Zhang K, Tasnim F, Chow PY, Zink D, Ying JY. Characterization of membrane materials and membrane coatings for bioreactor units of bioartificial kidneys. Biomaterials 32: 1465-1476, 2011.
19. Ni M, Zimmermann PK, Kandasamy K, Lai W, Li Y, Leong MF, Wan AC, Zink D. The use of a library of industrial materials to determine the nature of substrate-dependent performance of primary adherent human cells. Biomaterials 33: 353-364, 2012.
20. Pfaller W, Gstraunthaler G. Nephrotoxicity testing in vitro-what we know and what we need to know. Environ Health Perspect 106, Suppl 2: 559-569, 1998.
21. Phillips AO, Steadman R. Diabetic nephropathy: the central role of renal proximal tubular cells in tubulointerstitial injury. Histol Histopathol 17: 247-252, 2002.
22. Prieto P. Barriers, nephrotoxicology and chronic testing in vitro. Altern Lab Anim 30, Suppl 2: 101-106, 2002.
23. Saito A, Sawada K, Fujimura S. Present status and future perspectives on the development of bioartificial kidneys for the treatment of acute and chronic renal failure patients. Hemodial Int 15: 183-192, 2011.
24. Salerno S, Campana C, Morelli S, Drioli E, De Bartolo L. Human hepatocytes and endothelial cells in organotypic membrane systems. Biomaterials 32: 8848-8859, 2011.
25. Sato W, Tanabe K, Kosugi T, Hudkins K, Lanaspa MA, Zhang L, Campbell-Thompson M, Li Q, Long DA, Alpers CE, Nakagawa T. Selective stimulation of VEGFR2 accelerates progressive renal disease. Am J Pathol 179: 155-166, 2011.
26. Schrijvers BF, Flyvbjerg A, De Vriese AS. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int 65: 2003-2017, 2004.
27. Simon M, Maresh JG, Harris SE, Hernandez JD, Arar M, Olson MS, Abboud HE. Expression of bone morphogenetic protein-7 mRNA in normal and ischemic adult rat kidney. Am J Physiol Renal Physiol 276: F382-F389, 1999.
28. Takayama G, Taniguchi A, Okano T. Identification of differentially expressed genes in hepatocyte/endothelial cell co-culture system. Tissue Eng 13: 159-166, 2007.
29. Tang SC, Leung JC, Lai KN. Diabetic tubulopathy: an emerging entity. Contrib Nephrol 170: 124-134, 2011.
30. Tasnim F, Deng R, Hu M, Liour S, Li Y, Ni M, Ying JY, Zink D. Achievements and challenges in bioartificial kidney development. Fibrogenesis Tissue Repair 3: 14, 2010.
31. Tasnim F, Kandasamy K, Muck JS, Bin Ibrahim MS, Ying JY, Zink D. Effects of bone morphogenetic proteins on primary human renal cells and the generation of bone morphogenetic protein-7-expressing cells for application in bioartificial kidneys. Tissue Eng Part A 18: 262-276, 2012.
32. Tufro-McReddie A, Norwood VF, Aylor KW, Botkin SJ, Carey RM, Gomez RA. Oxygen regulates vascular endothelial growth factor-mediated vasculogenesis and tubulogenesis. Dev Biol 183: 139-149, 1997.
33. Tufro A, Norwood VF, Carey RM, Gomez RA. Vascular endothelial growth factor induces nephrogenesis and vasculogenesis. J Am Soc Nephrol 10: 2125-2134, 1999.
34. Tumlin J, Wali R, Williams W, Murray P, Tolwani AJ, Vinnikova AK, Szerlip HM, Ye J, Paganini EP, Dworkin L, Finkel KW, Kraus MA, Humes HD. Efficacy and safety of renal tubule cell therapy for acute renal failure. J Am Soc Nephrol 19: 1034-1040, 2008.
35. Villegas G, Lange-Sperandio B, Tufro A. Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells. Kidney Int 67: 449-457, 2005.
36. Vukicevic S, Basic V, Rogic D, Basic N, Shih MS, Shepard A, Jin D, Dattatreyamurty B, Jones W, Dorai H, Ryan S, Griffiths D, Maliakal J, Jelic M, Pastorcic M, Stavljenic A, Sampath TK. Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat. J Clin Invest 102: 202-214, 1998.
37. Wagner Z, Degrell P, Lukats B, Niwa T, Molnar GA, Marko L, Karadi Z, Wittmann I. Accumulation of renin and imidazolone in peritubular capillary endothelial cells in insulin-resistant hypertensive rats. J Nephrol 24: 656-664, 2011.
38. Webb DJ, Wen J, Karns LR, Kurilla MG, Gonias SL. Localization of the binding site for transforming growth factor-beta in human alpha2-macroglobulin to a 20-kDa peptide that also contains the bait region. J Biol Chem 273: 13339-13346, 1998.
39. Wilson CO, Block JH, Gisvold O, Beale JM. Wilson and Gisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry. Philadelphia, PA: Lippincott Williams and Wilkins, 2004.
40. Wu Y, Connors D, Barber L, Jayachandra S, Hanumegowda UM, Adams SP. Multiplexed assay panel of cytotoxicity in HK-2 cells for detection of renal proximal tubule injury potential of compounds. Toxicol In Vitro 23: 1170-1178, 2009.
41. You WK, McDonald DM. The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis. BMB Rep 41: 833-839, 2008.
42. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9: 964-968, 2003.
43. Zhang H, Lau SF, Heng BF, Teo PY, Alahakoon PK, Ni M, Tasnim F, Ying JY, Zink D. Generation of easily accessible human kidney tubules on two-dimensional surfaces in vitro. J Cell Mol Med 15: 1287-1298, 2011.
44. Zhang H, Tasnim F, Ying JY, Zink D. The impact of extracellular matrix coatings on the performance of human renal cells applied in bioartificial kidneys. Biomaterials 30: 2899-2911, 2009.